220 related articles for article (PubMed ID: 29907328)
21. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
[TBL] [Abstract][Full Text] [Related]
22. Indolylkojyl methane analogue IKM5 potentially inhibits invasion of breast cancer cells via attenuation of GRP78.
Nayak D; Katoch A; Sharma D; Faheem MM; Chakraborty S; Sahu PK; Chikan NA; Amin H; Gupta AP; Gandhi SG; Mukherjee D; Goswami A
Breast Cancer Res Treat; 2019 Sep; 177(2):307-323. PubMed ID: 31175498
[TBL] [Abstract][Full Text] [Related]
23. Enhanced selenium effect on growth arrest by BiP/GRP78 knockdown in p53-null human prostate cancer cells.
Zu K; Bihani T; Lin A; Park YM; Mori K; Ip C
Oncogene; 2006 Jan; 25(4):546-54. PubMed ID: 16205645
[TBL] [Abstract][Full Text] [Related]
24. A peptidic unconjugated GRP78/BiP ligand modulates the unfolded protein response and induces prostate cancer cell death.
Maddalo D; Neeb A; Jehle K; Schmitz K; Muhle-Goll C; Shatkina L; Walther TV; Bruchmann A; Gopal SM; Wenzel W; Ulrich AS; Cato AC
PLoS One; 2012; 7(10):e45690. PubMed ID: 23049684
[TBL] [Abstract][Full Text] [Related]
25. Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway.
Zheng Y; Liu P; Wang N; Wang S; Yang B; Li M; Chen J; Situ H; Xie M; Lin Y; Wang Z
Oxid Med Cell Longev; 2019; 2019():8781690. PubMed ID: 31531187
[TBL] [Abstract][Full Text] [Related]
26. A murine monoclonal antibody directed against the carboxyl-terminal domain of GRP78 suppresses melanoma growth in mice.
de Ridder GG; Ray R; Pizzo SV
Melanoma Res; 2012 Jun; 22(3):225-35. PubMed ID: 22495669
[TBL] [Abstract][Full Text] [Related]
27. Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3.
Yao X; Liu H; Zhang X; Zhang L; Li X; Wang C; Sun S
PLoS One; 2015; 10(5):e0125634. PubMed ID: 25973748
[TBL] [Abstract][Full Text] [Related]
28. CHM-1 Suppresses Formation of Cell Surface-associated GRP78-p85α Complexes, Inhibiting PI3K-AKT Signaling and Inducing Apoptosis of Human Nasopharyngeal Carcinoma Cells.
Lin ML; Chen SS; Ng SH
Anticancer Res; 2015 Oct; 35(10):5359-68. PubMed ID: 26408697
[TBL] [Abstract][Full Text] [Related]
29. A computational peptide model induces cancer cells' apoptosis by docking Kringle 5 to GRP78.
Khater I; Nassar A
BMC Mol Cell Biol; 2023 Aug; 24(1):25. PubMed ID: 37553635
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative effect of p-Coumaric acid targets UPR activation by downregulating Grp78 in colon cancer.
Sharma SH; Rajamanickam V; Nagarajan S
Chem Biol Interact; 2018 Aug; 291():16-28. PubMed ID: 29879413
[TBL] [Abstract][Full Text] [Related]
31. Receptor-recognized α₂-macroglobulin binds to cell surface-associated GRP78 and activates mTORC1 and mTORC2 signaling in prostate cancer cells.
Misra UK; Pizzo SV
PLoS One; 2012; 7(12):e51735. PubMed ID: 23272152
[TBL] [Abstract][Full Text] [Related]
32. Peptide-binding heat shock protein GRP78 protects cardiomyocytes from hypoxia-induced apoptosis.
Hardy B; Raiter A
J Mol Med (Berl); 2010 Nov; 88(11):1157-67. PubMed ID: 20664993
[TBL] [Abstract][Full Text] [Related]
33. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development.
Dong D; Ni M; Li J; Xiong S; Ye W; Virrey JJ; Mao C; Ye R; Wang M; Pen L; Dubeau L; Groshen S; Hofman FM; Lee AS
Cancer Res; 2008 Jan; 68(2):498-505. PubMed ID: 18199545
[TBL] [Abstract][Full Text] [Related]
34. Cancer antineovascular therapy with liposome drug delivery systems targeted to BiP/GRP78.
Katanasaka Y; Ishii T; Asai T; Naitou H; Maeda N; Koizumi F; Miyagawa S; Ohashi N; Oku N
Int J Cancer; 2010 Dec; 127(11):2685-98. PubMed ID: 20178102
[TBL] [Abstract][Full Text] [Related]
35. Synergistic promotion of breast cancer cells death by targeting molecular chaperone GRP78 and heat shock protein 70.
Li M; Wang J; Jing J; Hua H; Luo T; Xu L; Wang R; Liu D; Jiang Y
J Cell Mol Med; 2009; 13(11-12):4540-50. PubMed ID: 19017364
[TBL] [Abstract][Full Text] [Related]
36. 17beta-hydroxysteroid dehydrogenase type 5 is negatively correlated to apoptosis inhibitor GRP78 and tumor-secreted protein PGK1, and modulates breast cancer cell viability and proliferation.
Xu D; Aka JA; Wang R; Lin SX
J Steroid Biochem Mol Biol; 2017 Jul; 171():270-280. PubMed ID: 28457968
[TBL] [Abstract][Full Text] [Related]
37. Treatment with panobinostat induces glucose-regulated protein 78 acetylation and endoplasmic reticulum stress in breast cancer cells.
Rao R; Nalluri S; Kolhe R; Yang Y; Fiskus W; Chen J; Ha K; Buckley KM; Balusu R; Coothankandaswamy V; Joshi A; Atadja P; Bhalla KN
Mol Cancer Ther; 2010 Apr; 9(4):942-52. PubMed ID: 20371724
[TBL] [Abstract][Full Text] [Related]
38. Quantum dot-conjugated anti-GRP78 scFv inhibits cancer growth in mice.
Xu W; Liu L; Brown NJ; Christian S; Hornby D
Molecules; 2012 Jan; 17(1):796-808. PubMed ID: 22249409
[TBL] [Abstract][Full Text] [Related]
39. Dietary compound isoliquiritigenin targets GRP78 to chemosensitize breast cancer stem cells via β-catenin/ABCG2 signaling.
Wang N; Wang Z; Peng C; You J; Shen J; Han S; Chen J
Carcinogenesis; 2014 Nov; 35(11):2544-54. PubMed ID: 25194164
[TBL] [Abstract][Full Text] [Related]
40. HHQ-4, a quinoline derivate, preferentially inhibits proliferation of glucose-deprived breast cancer cells as a GRP78 down-regulator.
Xiao X; Li S; Zhang X; Lu J; Wang W; Zhou S; Zhang J; Wang R; Li A
Toxicol Appl Pharmacol; 2019 Jun; 373():10-25. PubMed ID: 31022492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
